Jeonghee Cho

7PUBLICATIONS
15CO-AUTHORS
Molecular targetsCancer geneticsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 04, 2026
RAF1 extrachromosomal DNA amplification confers acquired erlotinib resistance in a non-small cell lung cancer cell model.

|Apr 22, 2026
Clinical and Molecular Characterization of a Rare EGFR cis Compound L833V/H835L Mutation in Non-Small Cell Lung Cancer.

|Aug 12, 2024
Functional loss of ERBB receptor feedback inhibitor 1 (MIG6) promotes glioblastoma tumorigenesis by aberrant activation of epidermal growth factor receptor (EGFR).

Sang Ah Yi, Daseul Cho, Sujin Kim

|Jul 02, 2021
Potentiating Therapeutic Effects of Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer.

Kyu Sic You, Yong Weon Yi, Jeonghee Cho

|Apr 03, 2021
Dual Inhibition of AKT and MEK Pathways Potentiates the Anti-Cancer Effect of Gefitinib in Triple-Negative Breast Cancer Cells.

Kyu Sic You, Yong Weon Yi, Jeonghee Cho

|Jul 11, 2019
Colorectal adenocarcinoma-derived EGFR mutants are oncogenic and sensitive to EGFR-targeted monoclonal antibodies, cetuximab and panitumumab.

Nayoung Kim, Daseul Cho, Hyunjin Kim

Pageof 2

Frequent Collaborators

2 joint publications

Kyu Sic You

2 joint publications

Yong Weon Yi

2 joint publications

Hyun-Soo Cho

2 joint publications

Ahjin Lim